EpiBiologics
- Business Model
- B2B
- Website
- epibiologics.com
- Total Funding
- $157.0M
- Last Round
- $50.0M Series AJan 2024
- Rounds
- 2
About
Biotech developing bispecific antibodies and targeted protein degradation therapies for oncology, focused on EGFR-driven cancers.
Summary
EpiBiologics is a Biotech company. It has raised $157.0M in total across 2 rounds, most recently a $50.0M Series A round in Jan 2024. Investors include Polaris Partners, Digitalis Ventures and JJDC.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...